Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
Key | |
---|---|
Module Score | Databases |
Where interaction is observed in another database a link is provided: |
Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
---|---|---|---|---|---|---|---|---|---|
RAF1 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 1.14E5 | Evidence | O | ||||
RAF1 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 2.65E4 | Evidence | O | ||||
RAF1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 1.88E4 | Evidence | |||||
RAF1 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 3.26E3 | Evidence | O | ||||
RAF1 | RAP1B | RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor | 317.0 | Evidence | |||||
RAF1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 115.0 | Evidence | |||||
RAF1 | NRAS | NRAS, HRAS1: GTPase NRas precursor | 114.0 | Evidence | O | ||||
RAF1 | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 105.0 | Evidence | |||||
RAF1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 105.0 | Evidence | |||||
RAF1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 105.0 | Evidence | O | ||||
RAF1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 85.20 | Evidence | |||||
RAF1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 69.40 | Evidence | |||||
RAF1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 69.40 | Evidence | |||||
RAF1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 69.40 | Evidence | |||||
RAF1 | STK38 | STK38, NDR1: Serine/threonine-protein kinase 38 | 64.00 | Evidence | |||||
RAF1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 64.00 | Evidence | |||||
RAF1 | CSK | CSK: Tyrosine-protein kinase CSK | 64.00 | Evidence | |||||
RAF1 | RGS2 | RGS2, G0S8: Regulator of G-protein signaling 2 | 59.5 | Evidence | |||||
RAF1 | RAC2 | RAC2: Ras-related C3 botulinum toxin substrate 2 precursor | 58.90 | Evidence | |||||
RAF1 | LYN | LYN: Tyrosine-protein kinase Lyn | 55.10 | Evidence | |||||
RAF1 | SYK | SYK: Tyrosine-protein kinase SYK | 55.10 | Evidence | |||||
RAF1 | CSNK2A1 | CSNK2A1: CSNK2A1 protein | 51.60 | Evidence | |||||
RAF1 | CRKL | CRKL: Crk-like protein | 51.60 | Evidence | |||||
RAF1 | STK38L | STK38L, KIAA0965, NDR2: Serine/threonine-protein kinase 38-like | 51.60 | Evidence | |||||
RAF1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 51.60 | Evidence | |||||
RAF1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 51.50 | Evidence | |||||
RAF1 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 51.50 | Evidence | O | ||||
RAF1 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 44.40 | Evidence | |||||
RAF1 | COPE | COPE: Coatomer subunit epsilon | 43.00 | Evidence | |||||
RAF1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 42.00 | Evidence | O | ||||
RAF1 | PRKCI | PRKCI, DXS1179E: Protein kinase C iota type | 39.10 | Evidence | |||||
RAF1 | SH3BP5 | N/A | 39.10 | Evidence | |||||
RAF1 | CD44 | N/A | 35.00 | Evidence | |||||
RAF1 | IRS2 | IRS2: Insulin receptor substrate 2 | 34.80 | Evidence | |||||
RAF1 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 34.00 | Evidence | |||||
RAF1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 33.90 | Evidence | O | ||||
RAF1 | PIP5K3 | PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase | 32.30 | Evidence | |||||
RAF1 | DAPK1 | DAPK1, DAPK: Death-associated protein kinase 1 | 31.20 | Evidence | |||||
RAF1 | CDK5 | CDK5: Cell division protein kinase 5 | 31.20 | Evidence | |||||
RAF1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 30.90 | Evidence | |||||
RAF1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 30.00 | Evidence | O | ||||
RAF1 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 27.80 | Evidence | |||||
RAF1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 26.40 | Evidence | |||||
RAF1 | CDC23 | CDC23: Cell division cycle protein 23 homolog | 26.00 | Evidence | |||||
RAF1 | PRKX | PRKX, PKX1: Serine/threonine-protein kinase PRKX | 25.00 | Evidence | |||||
RAF1 | YWHAG | YWHAG: 14-3-3 protein gamma | 22.90 | Evidence | O | ||||
RAF1 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 22.90 | Evidence | |||||
RAF1 | UTX | UTX: Ubiquitously transcribed X chromosome tetratricopeptide repeat protein | 22.40 | Evidence | |||||
RAF1 | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 22.40 | Evidence | |||||
RAF1 | PLEKHA5 | PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member | 22.40 | Evidence | |||||
RAF1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 22.30 | Evidence | |||||
RAF1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 22.20 | Evidence | |||||
RAF1 | HSP90AB1 | HSP90AB1, HSP90B, HSPC2, HSPCB: Heat shock protein HSP 90-beta | 21.40 | Evidence | O | ||||
RAF1 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 20.50 | Evidence | |||||
RAF1 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 20.50 | Evidence | |||||
RAF1 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 20.50 | Evidence | |||||
RAF1 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
RAF1 | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 20.50 | Evidence | |||||
RAF1 | CDC25C | CDC25C: M-phase inducer phosphatase 3 | 20.50 | Evidence | |||||
RAF1 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 20.50 | Evidence | |||||
RAF1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 20.50 | Evidence | |||||
RAF1 | RPS6KA4 | RPS6KA4, MSK2: Ribosomal protein S6 kinase alpha-4 | 20.50 | Evidence | |||||
RAF1 | STMN1 | STMN1, LAP18, OP18: Stathmin | 20.40 | Evidence | |||||
RAF1 | PPP2R5A | PPP2R5A: Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha | 20.20 | Evidence | |||||
RAF1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 20.00 | Evidence | |||||
RAF1 | MINK1 | MAP4K6, MINK1, MINK: Misshapen-like kinase 1 | 19.70 | Evidence | |||||
RAF1 | MAPK8 | MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 | 19.70 | Evidence | |||||
RAF1 | CASP9 | CASP9, MCH6: Caspase-9 precursor | 19.10 | Evidence | |||||
RAF1 | RIN1 | RIN1: Ras and Rab interactor 1 | 18.90 | Evidence | |||||
RAF1 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 18.70 | Evidence | |||||
RAF1 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 18.50 | Evidence | |||||
RAF1 | GAB1 | GAB1: GRB2-associated-binding protein 1 | 18.10 | Evidence | |||||
RAF1 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 17.60 | Evidence | |||||
RAF1 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
RAF1 | STAT3 | 17.60 | Evidence | ||||||
RAF1 | HLA-C | HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor | 16.80 | Evidence | |||||
RAF1 | GABRR1 | N/A | 16.60 | Evidence | |||||
RAF1 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 16.40 | Evidence | |||||
RAF1 | PGAM1 | PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 | 15.80 | Evidence | |||||
RAF1 | DNAJC7 | DNAJC7, TPR2, TTC2: DnaJ homolog subfamily C member 7 | 15.70 | Evidence | |||||
RAF1 | CDKN1B | CDKN1B, KIP1: Cyclin-dependent kinase inhibitor 1B | 15.30 | Evidence | |||||
RAF1 | NAP1L1 | NAP1L1, NRP: Nucleosome assembly protein 1-like 1 | 15.30 | Evidence | |||||
RAF1 | SNCG | SNCG, BCSG1, PERSYN, PRSN: Gamma-synuclein | 15.30 | Evidence | |||||
RAF1 | MAP3K14 | MAP3K14, NIK: Mitogen-activated protein kinase kinase kinase 14 | 15.10 | Evidence | |||||
RAF1 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 15.10 | Evidence | |||||
RAF1 | IRS1 | IRS1: Insulin receptor substrate 1 | 15.00 | Evidence | |||||
RAF1 | PLCB1 | PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- | 13.70 | Evidence | |||||
RAF1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.70 | Evidence | O | ||||
RAF1 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 13.50 | Evidence | |||||
RAF1 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 13.50 | Evidence | |||||
RAF1 | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 13.50 | Evidence | |||||
RAF1 | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.50 | Evidence | |||||
RAF1 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 13.40 | Evidence | |||||
RAF1 | JUND | JUND: Transcription factor jun-D | 13.30 | Evidence | |||||
RAF1 | GRIN1 | GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor | 13.20 | Evidence | |||||
RAF1 | PTPRC | PTPRC, RP11-553K8.4-001, hCG_1811178: Protein tyrosine phosphatase, receptor typ | 13.00 | Evidence | |||||
RAF1 | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 13.00 | Evidence | |||||
RAF1 | RAB4A | N/A | 13.00 | Evidence | |||||
RAF1 | KRT1 | KRT1, KRTA: Keratin, type II cytoskeletal 1 | 12.50 | Evidence | |||||
RAF1 | PTGIR | PTGIR, PRIPR: Prostacyclin receptor | 12.40 | Evidence | |||||
RAF1 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 12.10 | Evidence | O | ||||
RAF1 | EPB41L3 | EPB41L3, DAL1, KIAA0987: Band 4.1-like protein 3 | 12.10 | Evidence | |||||
RAF1 | MICAL-L1 | MICALL1, KIAA1668, MIRAB13: MICAL-like protein 1 | 11.90 | Evidence | |||||
RAF1 | UBAP2 | N/A | 11.80 | Evidence | |||||
RAF1 | NEK8 | NEK8, JCK, NEK12A: Serine/threonine-protein kinase Nek8 | 11.60 | Evidence | |||||
RAF1 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 11.60 | Evidence | |||||
RAF1 | CDC2L1 | CDC2L1, PITSLREA, PK58: PITSLRE serine/threonine-protein kinase CDC2L1 | 11.50 | Evidence | |||||
RAF1 | NCF2 | NCF2: Neutrophil cytosol factor 2 | 11.50 | Evidence | |||||
RAF1 | MGMT | MGMT: Methylated-DNA--protein-cysteine methyltransferase | 11.5 | Evidence | |||||
RAF1 | RHOB | RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor | 11.20 | Evidence | |||||
RAF1 | PIK4CB | PIK4CB, RP11-126K1.4-003, hCG_1811976: Phosphatidylinositol 4-kinase, catalytic, | 10.80 | Evidence | |||||
RAF1 | TESK1 | TESK1: Dual specificity testis-specific protein kinase 1 | 10.60 | Evidence | |||||
RAF1 | EPRS | EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: | 10.60 | Evidence | |||||
RAF1 | CHC1 | RCC1: RCC1-I (Fragment) | 10.50 | Evidence | |||||
RAF1 | RASGRP2 | RASGRP2: RAS guanyl-releasing protein 2 | 10.30 | Evidence | |||||
RAF1 | TSC2 | TSC2, TSC4: Tuberin | 10.30 | Evidence | |||||
RAF1 | LRRC7 | LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 | 10.30 | Evidence | |||||
RAF1 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 10.30 | Evidence | |||||
RAF1 | RNPS1 | RNPS1, LDC2: RNA-binding protein with serine-rich domain 1 | 10.20 | Evidence | |||||
RAF1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 10.10 | Evidence | |||||
RAF1 | AMPH | AMPH, AMPH1: Amphiphysin | 9.96 | Evidence | |||||
RAF1 | MARK2 | N/A | 9.76 | Evidence | |||||
RAF1 | MAPK7 | mitogen-activated protein kinase 7 isoform 1 | 9.76 | Evidence | |||||
RAF1 | PAPOLA | PAPOLA, PAP: Poly(A) polymerase alpha | 9.17 | Evidence | |||||
RAF1 | CBX3 | CBX3: Chromobox protein homolog 3 | 9.15 | Evidence | |||||
RAF1 | MAD1L1 | MAD1L1, MAD1, TXBP181: Mitotic spindle assembly checkpoint protein MAD1 | 8.74 | Evidence | |||||
RAF1 | BCL2 | BCL2: Apoptosis regulator Bcl-2 | 8.69 | Evidence | |||||
RAF1 | BCL2L1 | BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X | 7.72 | Evidence | |||||
RAF1 | JUN | JUN: Transcription factor AP-1 | 7.56 | Evidence | |||||
RAF1 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 7.56 | Evidence | |||||
RAF1 | RPA2 | RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit | 7.52 | Evidence | |||||
RAF1 | SMARCA5 | SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul | 7.38 | Evidence | |||||
RAF1 | FOS | FOS, G0S7: Proto-oncogene protein c-fos | 7.38 | Evidence | |||||
RAF1 | MNAR | PELP1, HMX3, MNAR: Proline-, glutamic acid- and leucine-rich protein 1 | 7.20 | Evidence | |||||
RAF1 | PTPRA | N/A | 7.14 | Evidence | |||||
RAF1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 7.05 | Evidence | |||||
RAF1 | BID | BID: BH3-interacting domain death agonist | 6.82 | Evidence | |||||
RAF1 | PARD3 | N/A | 6.81 | Evidence | |||||
RAF1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 6.80 | Evidence | |||||
RAF1 | EPOR | EPOR: Erythropoietin receptor precursor | 6.78 | Evidence | |||||
RAF1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 6.73 | Evidence | O | ||||
RAF1 | AQP2 | AQP2: Aquaporin-2 | 6.66 | Evidence | |||||
RAF1 | SORBS3 | SORBS3, SCAM1: Vinexin | 6.66 | Evidence | |||||
RAF1 | INSR | INSR: Insulin receptor precursor | 6.63 | Evidence | |||||
RAF1 | TUBB | TUBB, TUBB5, OK/SW-cl.56: Tubulin beta chain | 6.50 | Evidence | |||||
RAF1 | PSMC2 | PSMC2, MSS1: 26S protease regulatory subunit 7 | 6.45 | Evidence | |||||
RAF1 | PPP1R12C | PPP1R12C, MBS85: Protein phosphatase 1 regulatory subunit 12C | 6.40 | Evidence | |||||
RAF1 | SLC9A3R2 | SLC9A3R2: SLC9A3R2 protein (Fragment) | 6.40 | Evidence | |||||
RAF1 | SF1 | SF1, ZFM1, ZNF162: Splicing factor 1 | 6.40 | Evidence | |||||
RAF1 | TH | TH, TYH: Tyrosine 3-monooxygenase | 6.39 | Evidence | |||||
RAF1 | GRB10 | N/A | 6.14 | Evidence | |||||
RAF1 | RASGRF1 | RASGRF1, CDC25: Guanine nucleotide-releasing protein | 6.11 | Evidence | |||||
RAF1 | TUBA1 | TUBA4A, TUBA1: Tubulin alpha-4A chain | 6.06 | Evidence | |||||
RAF1 | EP300 | N/A | 6.01 | Evidence | |||||
RAF1 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 5.97 | Evidence | |||||
RAF1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 5.97 | Evidence | |||||
RAF1 | PEA15 | PEA15: Astrocytic phosphoprotein PEA-15 | 5.90 | Evidence | |||||
RAF1 | AHNAK | AHNAK: AHNAK protein | 5.9 | Evidence | |||||
RAF1 | PRKACG | PRKACG: cAMP-dependent protein kinase, gamma-catalytic subunit | 5.89 | Evidence | |||||
RAF1 | LSP1 | LSP1, WP34: Lymphocyte-specific protein 1 | 5.87 | Evidence | |||||
RAF1 | HSPB8 | HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 | 5.86 | Evidence | |||||
RAF1 | HSPA8 | HSPA8, HSC70, HSP73, HSPA10: Heat shock cognate 71 kDa protein | 5.73 | Evidence | |||||
RAF1 | DPP8 | DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 | 5.73 | Evidence | |||||
RAF1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 5.63 | Evidence | |||||
RAF1 | PTPN11 | N/A | 5.55 | Evidence | |||||
RAF1 | FKBP1A | FKBP1A, FKBP1, FKBP12: FK506-binding protein 1A | 5.55 | Evidence | |||||
RAF1 | TAF10 | TAF2A, TAF10, TAF2H, TAFII30: Transcription initiation factor TFIID subunit 10 | 5.54 | Evidence | |||||
RAF1 | KIAA0788 | ASCC3L1, HELIC2, KIAA0788: U5 small nuclear ribonucleoprotein 200 kDa helicase | 5.54 | Evidence | |||||
RAF1 | TDG | TDG: G/T mismatch-specific thymine DNA glycosylase | 5.54 | Evidence | |||||
RAF1 | TOP2B | N/A | 5.32 | Evidence | |||||
RAF1 | RACGAP1 | RACGAP1, KIAA1478, MGCRACGAP: Rac GTPase-activating protein 1 | 5.28 | Evidence | |||||
RAF1 | ADAM33 | ADAM33, UNQ873/PRO1891: ADAM 33 precursor | 5.26 | Evidence | |||||
RAF1 | NPPC | NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- | 5.08 | Evidence | |||||
RAF1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 4.77 | Evidence | |||||
RAF1 | PPP1R8 | N/A | 4.77 | Evidence | |||||
RAF1 | TPH1 | N/A | 4.69 | Evidence | |||||
RAF1 | GNA12 | GNA12: Guanine nucleotide-binding protein alpha-12 subunit | 4.63 | Evidence | |||||
RAF1 | KRT18 | KRT18: Uncharacterized protein KRT18 | 4.48 | Evidence | |||||
RAF1 | LEPR | LEPR, DB, OBR: Leptin receptor precursor | 4.48 | Evidence | |||||
RAF1 | ZFP36 | ZFP36, G0S24, RNF162A, TIS11A, TTP: Tristetraproline | 4.47 | Evidence | |||||
RAF1 | MDM4 | MDM4, MDMX: Mdm4 protein | 4.38 | Evidence | |||||
RAF1 | NDP | NDP: Norrin precursor | 4.35 | Evidence | |||||
RAF1 | UBTF | UBTF, UBF, UBF1: Nucleolar transcription factor 1 | 4.30 | Evidence | |||||
RAF1 | ATP1A1 | ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor | 4.28 | Evidence | |||||
RAF1 | CASP3 | CASP3, CPP32: Caspase-3 precursor | 4.23 | Evidence | |||||
RAF1 | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 4.23 | Evidence | |||||
RAF1 | ARAF | ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase | 4.22 | Evidence | |||||
RAF1 | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.19 | Evidence | |||||
RAF1 | C1QBP | C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot | 4.19 | Evidence | |||||
RAF1 | DUSP2 | DUSP2, PAC1: Dual specificity protein phosphatase 2 | 4.16 | Evidence | |||||
RAF1 | TSC1 | TSC1, KIAA0243, TSC: Hamartin | 4.01 | Evidence | |||||
RAF1 | GRIN2A | GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor | 3.9 | Evidence | |||||
RAF1 | MATK | 3.88 | Evidence | ||||||
RAF1 | PTPN7 | N/A | 3.88 | Evidence | |||||
RAF1 | CEBPB | CEBPB, TCF5, PP9092: CCAAT/enhancer-binding protein beta | 3.85 | Evidence | |||||
RAF1 | TP53 | TP53, P53: Cellular tumor antigen p53 | 3.85 | Evidence | |||||
RAF1 | GRAP | GRAP: GRB2-related adapter protein | 3.83 | Evidence | |||||
RAF1 | NPR3 | NPR3, ANPRC: Atrial natriuretic peptide clearance receptor precursor | 3.78 | Evidence | |||||
RAF1 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 3.70 | Evidence | |||||
RAF1 | OSBPL6 | OSBPL6, ORP6: Oxysterol-binding protein-related protein 6 | 3.70 | Evidence | |||||
RAF1 | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 3.70 | Evidence | |||||
RAF1 | GJB1 | GJB1, CX32: Gap junction beta-1 protein | 3.64 | Evidence | |||||
RAF1 | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 3.62 | Evidence | |||||
RAF1 | BAD | BAD, BBC6, BCL2L8: Bcl2 antagonist of cell death | 3.51 | Evidence | |||||
RAF1 | NGFR | NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor | 3.48 | Evidence | |||||
RAF1 | RAD51 | RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 | 3.47 | Evidence | |||||
RAF1 | FBXO4 | FBXO4, FBX4: F-box only protein 4 | 3.34 | Evidence | |||||
RAF1 | PAK1IP1 | PAK1IP1, PIP1, WDR84: p21-activated protein kinase-interacting protein 1 | 3.30 | Evidence | |||||
RAF1 | TUBB2A | TUBB2A, TUBB2: Tubulin beta-2A chain | 3.27 | Evidence | |||||
RAF1 | PEBP1 | PEBP1, PBP, PEBP: Phosphatidylethanolamine-binding protein 1 | 3.26 | Evidence | O | ||||
RAF1 | KRT8 | KRT8, CYK8: Keratin, type II cytoskeletal 8 | 3.07 | Evidence | |||||
RAF1 | ST3GAL1 | ST3GAL1, SIAT4, SIAT4A: CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sia | 3.02 | Evidence | |||||
RAF1 | MAP2K3 | N/A | 2.99 | Evidence | |||||
RAF1 | EGF | EGF: Pro-epidermal growth factor precursor | 2.94 | Evidence | |||||
RAF1 | CHRM2 | CHRM2: Muscarinic acetylcholine receptor M2 | 2.85 | Evidence | |||||
RAF1 | HIF1A | HIF1A, MOP1: Hypoxia-inducible factor 1 alpha | 2.84 | Evidence | |||||
RAF1 | HDAC4 | HDAC4, KIAA0288: Histone deacetylase 4 | 2.84 | Evidence | |||||
RAF1 | TCF3 | TCF3, E2A, ITF1: Transcription factor E2-alpha | 2.84 | Evidence | |||||
RAF1 | SMAD4 | SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 | 2.70 | Evidence | |||||
RAF1 | FOSL2 | FOSL2, FRA2: Fos-related antigen 2 | 2.70 | Evidence | |||||
RAF1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 2.34 | Evidence | |||||
RAF1 | ETS1 | ETS1, EWSR2: Protein C-ets-1 | 2.33 | Evidence | |||||
RAF1 | PTPNS1 | N/A | 2.29 | Evidence | |||||
RAF1 | REM1 | REM1, GES, REM: GTP-binding protein REM 1 | 2.18 | Evidence | |||||
RAF1 | NFIA | NFIA, RP5-902P15.1-003, hCG_2032260: Nuclear factor I/A | 1.98 | Evidence | |||||
RAF1 | LOC642558 | FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 | 1.98 | Evidence | |||||
RAF1 | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 1.94 | Evidence | |||||
RAF1 | PARVA | PARVA, MXRA2: Alpha-parvin | 1.84 | Evidence | |||||
RAF1 | MAPT | N/A | 1.81 | Evidence | |||||
RAF1 | TAL2 | TAL2: T-cell acute lymphocytic leukemia protein 2 | 1.78 | Evidence | |||||
RAF1 | ENO2 | ENO2: Gamma-enolase | 1.77 | Evidence | |||||
RAF1 | GRIN2D | GRIN2D, NMDAR2D: Glutamate [NMDA] receptor subunit epsilon-4 precursor | 1.71 | Evidence | |||||
RAF1 | RAVER1 | RAVER1, KIAA1978: Ribonucleoprotein PTB-binding 1 | 1.71 | Evidence | |||||
RAF1 | NES | N/A | 1.71 | Evidence | |||||
RAF1 | JDP2 | jdp2, JDP2: Jun dimerization protein 2 | 1.71 | Evidence | |||||
RAF1 | IRF7 | N/A | 1.71 | Evidence | |||||
RAF1 | ARPC4 | ARPC4, ARC20: Actin-related protein 2/3 complex subunit 4 | 1.69 | Evidence | |||||
RAF1 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 1.64 | Evidence | |||||
RAF1 | SAP14 | SF3B14, CGI-110, HSPC175, HT006: Pre-mRNA branch site protein p14 | 1.53 | Evidence | |||||
RAF1 | MAPK8IP3 | N/A | 1.53 | Evidence | |||||
RAF1 | SMAD7 | SMAD7, MADH7, MADH8: Mothers against decapentaplegic homolog 7 | 1.48 | Evidence | |||||
RAF1 | TAL1 | TAL1, SCL, TCL5: T-cell acute lymphocytic leukemia protein 1 | 1.41 | Evidence | |||||
RAF1 | PRKACB | N/A | 1.33 | Evidence | |||||
RAF1 | ZNF295 | ZNF295, KIAA1227, ZBTB21: Zinc finger protein 295 | 1.30 | Evidence | |||||
RAF1 | PPARA | PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha | 1.27 | Evidence | |||||
RAF1 | ZA20D1 | OTUD7B, ZA20D1: OTU domain-containing protein 7B | 1.21 | Evidence | |||||
RAF1 | CTSZ | CTSZ: Cathepsin Z precursor | 1.19 | Evidence | |||||
RAF1 | HDAC5 | HDAC5, KIAA0600: Histone deacetylase 5 | 1.17 | Evidence | |||||
RAF1 | ELK1 | ELK1: ETS domain-containing protein Elk-1 | 1.17 | Evidence | |||||
RAF1 | HNRPD | HNRPD, AUF1: Heterogeneous nuclear ribonucleoprotein D0 | 1.16 | Evidence | |||||
RAF1 | ESR1 | ESR1, ESR, NR3A1: Estrogen receptor | 1.14 | Evidence | |||||
RAF1 | GP5 | GP5: Platelet glycoprotein V precursor | 1.00 | Evidence | |||||
RAF1 | PDLIM5 | PDLIM5, ENH: PDZ and LIM domain protein 5 | 0.99 | Evidence | |||||
RAF1 | SHOC2 | SHOC2, KIAA0862: Leucine-rich repeat protein SHOC-2 | 0.955 | Evidence | O | ||||
RAF1 | CCND2 | CCND2: G1/S-specific cyclin-D2 | 0.84 | Evidence | |||||
RAF1 | PRKAR1A | PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato | 0.785 | Evidence | |||||
RAF1 | NCF4 | NCF4, SH3PXD4: Neutrophil cytosol factor 4 | 0.738 | Evidence | |||||
RAF1 | RHOA | RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor | 0.738 | Evidence | |||||
RAF1 | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 0.738 | Evidence | |||||
RAF1 | MSN | MSN: Moesin | 0.66 | Evidence | |||||
RAF1 | PRPF4B | PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol | 0.66 | Evidence | |||||
RAF1 | OXSR1 | OXSR1, KIAA1101, OSR1: Serine/threonine-protein kinase OSR1 | 0.66 | Evidence | |||||
RAF1 | CENTB2 | CENTB2, KIAA0041: Centaurin-beta 2 | 0.66 | Evidence | |||||
RAF1 | RAP1A | RAP1A, KREV1: Ras-related protein Rap-1A precursor | 0.66 | Evidence | O | ||||
RAF1 | PTEN | PTEN, MMAC1, TEP1: Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and du | 0.66 | Evidence | |||||
RAF1 | CPN2 | CPN2, ACBP: Carboxypeptidase N subunit 2 precursor | 0.575 | Evidence | |||||
RAF1 | VASP | VASP: Vasodilator-stimulated phosphoprotein | 0.445 | Evidence | |||||
RAF1 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 0.445 | Evidence | |||||
RAF1 | OSBPL11 | OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 | 0.445 | Evidence | |||||
RAF1 | PSCD4 | PSCD4, CYT4: Cytohesin-4 | 0.4 | Evidence | |||||
RAF1 | ARHGEF6 | ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 | 0.4 | Evidence | |||||
RAF1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 0.4 | Evidence | |||||
RAF1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 0.4 | Evidence | |||||
RAF1 | PSMB7 | PSMB7: Proteasome subunit beta type-7 precursor | 0.4 | Evidence | |||||
RAF1 | HCK | N/A | 0.4 | Evidence | |||||
RAF1 | STK10 | STK10: Uncharacterized protein STK10 | 0.4 | Evidence | |||||
RAF1 | RPS6KB2 | RPS6KB2, STK14B: Ribosomal protein S6 kinase beta-2 | 0.4 | Evidence | |||||
RAF1 | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 0.4 | Evidence | |||||
RAF1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 0.367 | Evidence | |||||
RAF1 | TLK1 | TLK1, KIAA0137: Serine/threonine-protein kinase tousled-like 1 | 0.36 | Evidence | |||||
RAF1 | ROCK1 | ROCK1: Rho-associated protein kinase 1 | 0.36 | Evidence | |||||
RAF1 | MAP3K5 | MAP3K5, ASK1, MAPKKK5, MEKK5: Mitogen-activated protein kinase kinase kinase 5 | 0.36 | Evidence | O | ||||
RAF1 | FOSL1 | FOSL1, FRA1: Fos-related antigen 1 | 0.35 | Evidence | |||||
RAF1 | LOC387841 | hCG_27695: Uncharacterized protein ENSP00000349505 | 0.34 | Evidence | |||||
RAF1 | LOC283340 | similar to ribosomal protein L13a | 0.34 | Evidence | |||||
RAF1 | NULL | N/A | 0.34 | Evidence | |||||
RAF1 | GMIP | GMIP: GEM-interacting protein | 0.333 | Evidence | |||||
RAF1 | WASPIP | N/A | 0.333 | Evidence | |||||
RAF1 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 0.333 | Evidence | |||||
RAF1 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 0.333 | Evidence | |||||
RAF1 | YWHAZ | YWHAZ: 14-3-3 protein zeta/delta | 0.323 | Evidence | O | ||||
RAF1 | DOK1 | DOK1: Docking protein 1 | 0.323 | Evidence | |||||
RAF1 | ACP1 | ACP1: Low molecular weight phosphotyrosine protein phosphatase | 0.323 | Evidence | |||||
RAF1 | DYNC1LI1 | DYNC1LI1, DNCLI1: Cytoplasmic dynein 1 light intermediate chain 1 | 0.323 | Evidence | |||||
RAF1 | MAPKAPK3 | MAPKAPK3: MAP kinase-activated protein kinase 3 | 0.323 | Evidence | |||||
RAF1 | PRKD2 | PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 | 0.323 | Evidence | |||||
RAF1 | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 0.323 | Evidence | O | ||||
RAF1 | RPS6KB1 | N/A | 0.323 | Evidence | |||||
RAF1 | EEF2 | EEF2, EF2: Elongation factor 2 | 0.323 | Evidence | |||||
RAF1 | JAK1 | 0.323 | Evidence | O | |||||
RAF1 | SCYL3 | SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin | 0.323 | Evidence | |||||
RAF1 | PSMA5 | PSMA5: Proteasome subunit alpha type-5 | 0.323 | Evidence | |||||
RAF1 | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 0.323 | Evidence | |||||
RAF1 | NEK7 | NEK7: Serine/threonine-protein kinase Nek7 | 0.323 | Evidence | |||||
RAF1 | PSMA2 | PSMA2, PSC3: Proteasome subunit alpha type-2 | 0.323 | Evidence | |||||
RAF1 | PSMA3 | PSMA3, PSC8: Proteasome subunit alpha type-3 | 0.323 | Evidence | |||||
RAF1 | TPD52L1 | TPD52L1: Tumor protein D53 | 0.31 | Evidence | |||||
RAF1 | TOMM20 | TOMM20, KIAA0016: Mitochondrial import receptor subunit TOM20 homolog | 0.307 | Evidence | |||||
RAF1 | SHMT1 | SHMT1: Serine hydroxymethyltransferase, cytosolic | 0.305 | Evidence | |||||
RAF1 | RP11-365K22.1 | RP11-365K22.1-001: OTTHUMP00000018470 | 0.295 | Evidence | |||||
RAF1 | LOC644511 | similar to ribosomal protein L13a isoform 1 | 0.295 | Evidence | |||||
RAF1 | NULL | N/A | 0.295 | Evidence | |||||
RAF1 | LOC646469 | Uncharacterized protein ENSP00000368241 | 0.295 | Evidence | |||||
RAF1 | PLEK | PLEK, P47: Pleckstrin | 0.295 | Evidence | |||||
RAF1 | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 0.295 | Evidence | |||||
RAF1 | TGFB1 | TGFB1, TGFB: Transforming growth factor beta-1 precursor | 0.275 | Evidence | |||||
RAF1 | YWHAQ | YWHAQ: 14-3-3 protein theta | 0.265 | Evidence | O | ||||
RAF1 | GAB2 | N/A | 0.265 | Evidence | |||||
RAF1 | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 0.265 | Evidence | |||||
RAF1 | RIPK1 | RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 | 0.265 | Evidence | |||||
RAF1 | ATF1 | ATF1: Cyclic AMP-dependent transcription factor ATF-1 | 0.263 | Evidence | |||||
RAF1 | NEK9 | NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 | 0.263 | Evidence | |||||
RAF1 | CKS1B | CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 | 0.253 | Evidence | |||||
RAF1 | RHOG | RHOG, ARHG: Rho-related GTP-binding protein RhoG precursor | 0.247 | Evidence | |||||
RAF1 | CDC42 | CDC42: Cell division control protein 42 homolog precursor | 0.247 | Evidence | |||||
RAF1 | PARD6B | PARD6B, PAR6B: Partitioning defective 6 homolog beta | 0.245 | Evidence | |||||
RAF1 | ARHGDIB | ARHGDIB, GDIA2, GDID4, RAP1GN1: Rho GDP-dissociation inhibitor 2 | 0.237 | Evidence | |||||
RAF1 | RAN | RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran | 0.237 | Evidence | |||||
RAF1 | EIF5B | EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B | 0.237 | Evidence | |||||
RAF1 | SGK3 | SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 | 0.237 | Evidence | |||||
RAF1 | STK25 | STK25, SOK1, YSK1: Serine/threonine-protein kinase 25 | 0.237 | Evidence | |||||
RAF1 | CDK2 | CDK2: Cell division protein kinase 2 | 0.237 | Evidence | |||||
RAF1 | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 0.237 | Evidence | |||||
RAF1 | CDK4 | CDK4: Cell division protein kinase 4 | 0.237 | Evidence | |||||
RAF1 | PTPN12 | PTPN12: Tyrosine-protein phosphatase non-receptor type 12 | 0.237 | Evidence | |||||
RAF1 | STK11 | STK11, LKB1, PJS: Serine/threonine-protein kinase 11 | 0.237 | Evidence | |||||
RAF1 | SGK | SGK, SGK1: Serine/threonine-protein kinase Sgk1 | 0.237 | Evidence | |||||
RAF1 | OSBP | OSBP, OSBP1: Oxysterol-binding protein 1 | 0.237 | Evidence | |||||
RAF1 | ELMO2 | ELMO2, CED12A, KIAA1834: Engulfment and cell motility protein 2 | 0.237 | Evidence | |||||
RAF1 | STK4 | STK4, MST1: Serine/threonine-protein kinase 4 | 0.237 | Evidence | |||||
RAF1 | VIL2 | N/A | 0.237 | Evidence | |||||
RAF1 | HMGN1 | HMGN1, HMG14: Non-histone chromosomal protein HMG-14 | 0.237 | Evidence | |||||
RAF1 | COPS5 | COPS5, CSN5, JAB1: COP9 signalosome complex subunit 5 | 0.233 | Evidence | |||||
RAF1 | CFLAR | CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec | 0.225 | Evidence | |||||
RAF1 | LIMS1 | N/A | 0.225 | Evidence | |||||
RAF1 | IKBKB | IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta | 0.225 | Evidence | |||||
RAF1 | KIAA0528 | KIAA0528: Uncharacterized protein KIAA0528 | 0.225 | Evidence | |||||
RAF1 | LASP1 | LASP1, MLN50: LIM and SH3 domain protein 1 | 0.225 | Evidence | |||||
RAF1 | PIK3CD | PIK3CD: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta i | 0.225 | Evidence | |||||
RAF1 | PSTPIP1 | PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 | 0.225 | Evidence | |||||
RAF1 | RPL13A | RPL13A: 60S ribosomal protein L13a | 0.22 | Evidence | |||||
RAF1 | STK16 | N/A | 0.217 | Evidence | |||||
RAF1 | MAPK6 | MAPK6, ERK3, PRKM6: Mitogen-activated protein kinase 6 | 0.217 | Evidence | |||||
RAF1 | MAP3K8 | MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 | 0.217 | Evidence | |||||
RAF1 | MAPKAPK2 | MAPKAPK2: MAP kinase-activated protein kinase 2 | 0.217 | Evidence | |||||
RAF1 | APPL | APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha | 0.217 | Evidence | |||||
RAF1 | PASK | PASK, KIAA0135: PAS domain-containing serine/threonine-protein kinase | 0.217 | Evidence | |||||
RAF1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 0.217 | Evidence | |||||
RAF1 | RBP2 | RBP2, CRBP2: Retinol-binding protein II, cellular | 0.207 | Evidence | |||||
RAF1 | GNG4 | GNG4, GNGT4: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 p | 0.205 | Evidence | |||||
RAF1 | SNX17 | SNX17, KIAA0064: Sorting nexin-17 | 0.203 | Evidence | |||||
RAF1 | STK24 | STK24, MST3, STK3: Serine/threonine-protein kinase 24 | 0.203 | Evidence | |||||
RAF1 | SEC24B | SEC24B: Protein transport protein Sec24B | 0.203 | Evidence | |||||
RAF1 | NMT1 | NMT1, NMT: Glycylpeptide N-tetradecanoyltransferase 1 | 0.203 | Evidence | |||||
RAF1 | TAGLN2 | TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein | 0.203 | Evidence | |||||
RAF1 | RGS19 | RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 | 0.203 | Evidence | |||||
RAF1 | ANAPC5 | ANAPC5, APC5: Anaphase-promoting complex subunit 5 | 0.203 | Evidence | |||||
RAF1 | FNBP1 | N/A | 0.203 | Evidence | |||||
RAF1 | CXorf9 | N/A | 0.203 | Evidence | |||||
RAF1 | RPS10 | RPS10: 40S ribosomal protein S10 | 0.203 | Evidence | |||||
RAF1 | KIAA1012 | KIAA1012: Protein TRS85 homolog | 0.203 | Evidence | |||||
RAF1 | IQGAP1 | IQGAP1, KIAA0051: Ras GTPase-activating-like protein IQGAP1 | 0.203 | Evidence | |||||
RAF1 | GNG7 | GNG7, GNGT7: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 p | 0.2 | Evidence | |||||
RAF1 | NACA | NACA, HSD48: Nascent polypeptide-associated complex subunit alpha | 0.198 | Evidence | |||||
RAF1 | EIF4G2 | EIF4G2, DAP5, OK/SW-cl.75: Eukaryotic translation initiation factor 4 gamma 2 | 0.198 | Evidence | |||||
RAF1 | GNAI3 | GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha | 0.198 | Evidence | |||||
RAF1 | IQGAP2 | IQGAP2: Ras GTPase-activating-like protein IQGAP2 | 0.198 | Evidence | |||||
RAF1 | PLCB3 | PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 | 0.195 | Evidence | |||||
RAF1 | IQSEC1 | IQSEC1, ARFGEP100, BRAG2, KIAA0763: IQ motif and Sec7 domain-containing protein | 0.195 | Evidence | |||||
RAF1 | GRAP2 | GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 | 0.195 | Evidence | |||||
RAF1 | CDK7 | CDK7, MO15: Cell division protein kinase 7 | 0.195 | Evidence | |||||
RAF1 | STK3 | STK3, MST2: Serine/threonine-protein kinase 3 | 0.195 | Evidence | |||||
RAF1 | CHEK1 | CHEK1, CHK1: Serine/threonine-protein kinase Chk1 | 0.195 | Evidence | |||||
RAF1 | TRADD | TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein | 0.182 | Evidence | |||||
RAF1 | ZYX | ZYX: Zyxin | 0.182 | Evidence | |||||
RAF1 | NCF1 | Neutrophil cytosolic factor 1 variant (Fragment) | 0.182 | Evidence | |||||
RAF1 | RAB8A | RAB8A: RAB8A protein | 0.177 | Evidence | |||||
RAF1 | AHCY | AHCY, SAHH: Adenosylhomocysteinase | 0.172 | Evidence | |||||
RAF1 | SQSTM1 | SQSTM1: Uncharacterized protein SQSTM1 | 0.165 | Evidence | |||||
RAF1 | PLCG1 | PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 | 0.165 | Evidence | |||||
RAF1 | SRPK2 | SRPK2: Serine/threonine-protein kinase SRPK2 | 0.165 | Evidence | |||||
RAF1 | MLH1 | MLH1, COCA2: DNA mismatch repair protein Mlh1 | 0.163 | Evidence | |||||
RAF1 | TLN1 | TLN1: Uncharacterized protein TLN1 | 0.163 | Evidence | |||||
RAF1 | PSMD11 | PSMD11: 26S proteasome non-ATPase regulatory subunit 11 | 0.163 | Evidence | |||||
RAF1 | ATR | ATR, FRP1: Serine/threonine-protein kinase ATR | 0.163 | Evidence | |||||
RAF1 | CD2AP | CD2AP: CD2-associated protein | 0.163 | Evidence | |||||
RAF1 | TMEM1 | TMEM1, EHOC1: Transmembrane protein 1 | 0.163 | Evidence | |||||
RAF1 | COPS3 | COPS3, CSN3: COP9 signalosome complex subunit 3 | 0.163 | Evidence | |||||
RAF1 | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 0.163 | Evidence | |||||
RAF1 | TBK1 | TBK1, NAK: Serine/threonine-protein kinase TBK1 | 0.163 | Evidence | |||||
RAF1 | NRBP1 | NRBP1, BCON3, NRBP: Nuclear receptor-binding protein | 0.163 | Evidence | |||||
RAF1 | LPXN | LPXN, LDLP: Leupaxin | 0.163 | Evidence | |||||
RAF1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 0.158 | Evidence | |||||
RAF1 | SSH1 | SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 | 0.158 | Evidence | |||||
RAF1 | SOS1 | SOS1: Son of sevenless homolog 1 | 0.158 | Evidence | |||||
RAF1 | MAP2K4 | MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k | 0.147 | Evidence | |||||
RAF1 | RANBP2 | RANBP2, NUP358: E3 SUMO-protein ligase RanBP2 | 0.147 | Evidence | |||||
RAF1 | TXK | TXK, PTK4: Tyrosine-protein kinase TXK | 0.147 | Evidence | |||||
RAF1 | CDK6 | CDK6: Cell division protein kinase 6 | 0.147 | Evidence | |||||
RAF1 | AURKA | AURKA, AIK, ARK1, AURA, BTAK, STK15, STK6: Serine/threonine-protein kinase 6 | 0.147 | Evidence | |||||
RAF1 | GRK5 | GRK5, GPRK5: G protein-coupled receptor kinase 5 | 0.147 | Evidence | |||||
RAF1 | MAP2K6 | MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki | 0.147 | Evidence | |||||
RAF1 | SNF1LK2 | SNF1LK2, KIAA0781, QIK: Serine/threonine-protein kinase SNF1-like kinase 2 | 0.147 | Evidence | |||||
RAF1 | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 0.147 | Evidence | |||||
RAF1 | STAT2 | STAT2: Signal transducer and activator of transcription 2 | 0.142 | Evidence | |||||
RAF1 | PSCD2 | N/A | 0.142 | Evidence | |||||
RAF1 | ITSN1 | ITSN1, ITSN, SH3D1A: Intersectin-1 | 0.142 | Evidence | |||||
RAF1 | DNM3 | DNM3: Uncharacterized protein DNM3 | 0.142 | Evidence | |||||
RAF1 | PSCD1 | PSCD1, D17S811E: Cytohesin-1 | 0.142 | Evidence | |||||
RAF1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 0.142 | Evidence | |||||
RAF1 | MAPK15 | N/A | 0.142 | Evidence | |||||
RAF1 | MAPK10 | MAPK10, JNK3, JNK3A, PRKM10: Mitogen-activated protein kinase 10 | 0.142 | Evidence | |||||
RAF1 | ABL2 | ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 | 0.142 | Evidence | |||||
RAF1 | MAP2K5 | N/A | 0.142 | Evidence | |||||
RAF1 | NF2 | NF2, SCH: Merlin | 0.142 | Evidence | |||||
RAF1 | PKN1 | PKN1, PKN, PRK1, PRKCL1: Serine/threonine-protein kinase N1 | 0.142 | Evidence | |||||
RAF1 | SLA2 | SLA2, C20orf156, SLAP2: Src-like-adapter 2 | 0.142 | Evidence | |||||
RAF1 | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 0.142 | Evidence | |||||
RAF1 | LNK | SH2B3, LNK: SH2B adapter protein 3 | 0.142 | Evidence | |||||
RAF1 | MAPK9 | MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 | 0.142 | Evidence | |||||
RAF1 | MATK | MATK, CTK, HYL: Megakaryocyte-associated tyrosine-protein kinase | 0.142 | Evidence | |||||
RAF1 | CMTM6 | CMTM6, CKLFSF6: CKLF-like MARVEL transmembrane domain-containing protein 6 | 0.135 | Evidence | |||||
RAF1 | LIMK2 | LIMK2: LIM domain kinase 2 | 0.135 | Evidence | |||||
RAF1 | TRAFD1 | TRAFD1, FLN29: TRAF-type zinc finger domain-containing protein 1 | 0.135 | Evidence | |||||
RAF1 | SLC9A3R1 | SLC9A3R1, NHERF: Ezrin-radixin-moesin-binding phosphoprotein 50 | 0.135 | Evidence | |||||
RAF1 | STIP1 | STIP1: Stress-induced-phosphoprotein 1 | 0.135 | Evidence | |||||
RAF1 | PRKDC | PRKDC, HYRC, HYRC1: DNA-dependent protein kinase catalytic subunit | 0.135 | Evidence | |||||
RAF1 | H1FX | H1FX: Histone H1x | 0.133 | Evidence | |||||
RAF1 | CSF2RB | CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor | 0.133 | Evidence | |||||
RAF1 | IFNGR1 | IFNGR1: Interferon-gamma receptor alpha chain precursor | 0.133 | Evidence | |||||
RAF1 | PRKAA1 | N/A | 0.133 | Evidence | |||||
RAF1 | SOCS3 | SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 | 0.133 | Evidence | |||||
RAF1 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 0.133 | Evidence | |||||
RAF1 | ICK | ICK, KIAA0936: Serine/threonine-protein kinase ICK | 0.133 | Evidence | |||||
RAF1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 0.133 | Evidence | |||||
RAF1 | ATP5A1 | ATP5A1, ATP5A, ATP5AL2, ATPM: ATP synthase subunit alpha, mitochondrial precurso | 0.13 | Evidence | |||||
RAF1 | ARHGEF7 | N/A | 0.128 | Evidence | |||||
RAF1 | KIAA1804 | MLK4, KIAA1804: Mitogen-activated protein kinase kinase kinase | 0.128 | Evidence | |||||
RAF1 | CAMK4 | CAMK4: Calcium/calmodulin-dependent protein kinase type IV | 0.128 | Evidence | |||||
RAF1 | EPB41L1 | EPB41L1, KIAA0338: Band 4.1-like protein 1 | 0.128 | Evidence | |||||
RAF1 | RASD1 | RASD1, AGS1, DEXRAS1: Dexamethasone-induced Ras-related protein 1 precursor | 0.128 | Evidence | |||||
RAF1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 0.128 | Evidence | |||||
RAF1 | PKN3 | PKN3, PKNBETA: Serine/threonine-protein kinase N3 | 0.128 | Evidence | |||||
RAF1 | ITSN2 | ITSN2, KIAA1256, SH3D1B, SWAP: Intersectin-2 | 0.128 | Evidence | |||||
RAF1 | RAB5B | RAB5B: Ras-related protein Rab-5B | 0.128 | Evidence | |||||
RAF1 | LATS1 | LATS1, WARTS: Serine/threonine-protein kinase LATS1 | 0.128 | Evidence | |||||
RAF1 | LATS2 | LATS2, KPM: Serine/threonine-protein kinase LATS2 | 0.128 | Evidence | |||||
RAF1 | ELMO1 | N/A | 0.128 | Evidence | |||||
RAF1 | MKNK2 | MKNK2, GPRK7, MNK2: MAP kinase-interacting serine/threonine-protein kinase 2 | 0.128 | Evidence | |||||
RAF1 | ARL5A | ARL5A, ARFLP5, ARL5: ADP-ribosylation factor-like protein 5A | 0.128 | Evidence | |||||
RAF1 | PHKG1 | PHKG1, PHKG: Phosphorylase b kinase gamma catalytic chain, skeletal muscle isofo | 0.128 | Evidence | |||||
RAF1 | CDC2L5 | CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 | 0.128 | Evidence | |||||
RAF1 | DGKD | DGKD, KIAA0145: Diacylglycerol kinase delta | 0.128 | Evidence | |||||
RAF1 | CDC2 | CDC2: Cell division control protein 2 homolog | 0.128 | Evidence | |||||
RAF1 | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 0.128 | Evidence | |||||
RAF1 | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 0.128 | Evidence | |||||
RAF1 | KIAA0031 | EFTUD2, KIAA0031, SNRP116: 116 kDa U5 small nuclear ribonucleoprotein component | 0.128 | Evidence | |||||
RAF1 | CAMK1D | CAMK1D: Calcium/calmodulin-dependent protein kinase type 1D | 0.128 | Evidence | |||||
RAF1 | EEF2K | EEF2K: Elongation factor 2 kinase | 0.128 | Evidence | |||||
RAF1 | AKT3 | AKT3: RAC-gamma serine/threonine-protein kinase | 0.128 | Evidence |